PURPOSE: To retrospectively analyze the outcome of patients with anaplastic thyroid
carcinoma (ATC) treated in the Erasmus MC. MATERIAL AND METHODS: Seventy-five ATC …

Background The aim of the present study was to investigate the role of a multimodality
treatment for anaplastic thyroid carcinoma (ATC). Methods Clinical data of 40 consecutive …

Background: Anaplastic thyroid carcinoma (ATC) is a malignancy with one of the highest
fatality rates. Here we report a retrospective study of the treatment and other factors …

Background Anaplastic thyroid cancer (ATC) is an aggressive malignant tumour with a poor
prognosis. The median overall survival is described in the literature to be just 6 months …

Background: Anaplastic thyroid carcinoma (ATC) accounts for< 5% of all thyroid
malignancies and is one of the most aggressive malignancies known. Survival is limited to …

Objective Treatment options for anaplastic thyroid carcinoma (ATC), which is one of the most
lethal human malignant tumors, include surgery, chemotherapy and radiotherapy usually …

Methods: We retrospectively reviewed a multinstitutional clinical series of 114 consecutive
patients treated between 1996 and 2012 for ATC. The outcomes of a combined treatment …

Background Anaplastic thyroid carcinoma (ATC), accounting for 5% to 15% of primary
malignant thyroid neoplasms, is one of the most aggressive solid tumors in humans …

Background Anaplastic thyroid carcinoma (ATC) is a notoriously aggressive malignancy
associated with a highly lethal clinical course despite therapeutic intervention. Our present …

Background Anaplastic thyroid carcinoma (ATC) is among the most aggressive human
malignancies. It is associated with a high rate of local recurrence and with poor prognosis …